Can You OD on Wegovy — and What Happens If You Take Too Much?

Step 1: Understand why dosing precision matters with a long-acting medicine

Wegovy is injected once a week, and that weekly rhythm reflects something important about how semaglutide behaves in the body. Its half-life is approximately one week, which means the medicine stays active for considerably longer than most people expect. If you inject a second pen within the same week by mistake, or use a higher-strength pen than the one prescribed, the effects don't simply double and vanish, they can accumulate and persist for days.

The licensed titration schedule for Wegovy starts at 0.25 mg and moves upward in roughly four-weekly steps, with 2.4 mg as the standard maintenance dose and, since the MHRA approved it in early 2026, 7.2 mg available as a higher maintenance option for some patients. Those steps exist because the body needs time to adjust to each new level. Skipping steps or injecting twice doesn't speed up results; it dramatically increases the risk of the side effects described below. The NHS medicines page for semaglutide is clear that dosing decisions belong with your prescriber, not with the patient acting alone.

One practical note: keeping your pen in the fridge door where you can see it is a genuinely useful habit, because an unexpected second pen is often the result of forgetting last week's injection, not of any intent to overdose. That small organisational step prevents a meaningful number of accidental double-doses.

Step 2: Recognise what overdose symptoms actually look like

Clinical case reports and the Wegovy prescribing information describe a consistent pattern when semaglutide is taken in excess. The most common effects are gastrointestinal: vomiting that won't settle, severe nausea, diarrhoea and abdominal pain. These can lead to dehydration quickly, particularly in older patients or those who already have reduced fluid intake.

Hypoglycaemia (dangerously low blood sugar) is a more serious concern when Wegovy is combined with insulin or sulfonylureas, which some patients with type 2 diabetes take alongside it. On its own, semaglutide rarely causes hypoglycaemia at prescribed doses, but in overdose the risk rises, especially in someone who has also eaten very little.

The MHRA's ongoing monitoring of GLP-1 medicines, including its January 2026 Drug Safety Update on acute pancreatitis as a known infrequent risk, reflects how seriously the regulator takes adverse events in this class. Severe, persistent stomach pain that spreads toward the back (with or without vomiting) is a reason to seek emergency help, regardless of whether an overdose has occurred. You can report any suspected adverse reactions through the MHRA Yellow Card scheme.

If you are considering stopping Wegovy because you have concerns about the medicine, our page on what happens when you stop Wegovy covers the evidence clearly.

Step 3: Know the right response if you think you've taken too much

There is no semaglutide antidote. That is a factual statement, not a reason for panic, it simply means that medical management is supportive: treating dehydration with fluids, monitoring blood sugar, managing nausea and observing the patient until the medicine clears the system. Because semaglutide's half-life is around seven days, that observation period can be several days long, which is why this is a hospital-level situation rather than one to manage at home.

If you believe you or someone else has taken too much Wegovy, the steps are straightforward. Call 999 if the person is unconscious, having a seizure or showing signs of severe allergic reaction. Call 111 or go to your nearest A&E for significant vomiting, severe abdominal pain, or if you're unsure of the dose taken. Tell the clinical team exactly what strength pen was used and, if possible, when the last two injections were given.

Do not induce vomiting. Semaglutide is injected under the skin, not swallowed, so there is no gastric absorption to interrupt. The medicine is already in circulation. Trying to treat an overdose at home is not appropriate for this drug class.

People thinking about Wegovy for the first time (including what the monitoring process looks like) may find our overview of who Wegovy is suitable for a useful starting point, or our broader guide to semaglutide for the clinical picture.

How a properly supervised prescription keeps this risk low

Most genuine overdose situations with Wegovy happen in one of three ways: a patient loses track of which week they injected; a pen is used at the wrong strength because of a dispensing mix-up; or, more rarely, a patient in distress uses more than prescribed. Proper clinical oversight addresses all three.

At nume, a GPhC-registered Independent Prescriber reviews each consultation personally before any medicine is dispatched. Dose increases require clinical re-review, not just a click. That isn't process for its own sake, it's the layer that catches the person whose dose should not go up yet, or whose combination of medicines needs a careful look. Our clinical team follows this approach on every order, including repeats.

If you have questions about how Wegovy is used safely, including what to do if you exercise regularly on treatment, the evidence is covered on our page about working out on Wegovy. For information on what the medicine costs through a regulated UK pharmacy, the Wegovy price page sets out what a legitimate prescription includes. And if you're ready to talk to a prescriber about whether semaglutide is right for you, the right place to start is a free consultation with our clinical team, and patients with body art may also want to read our guidance on how Wegovy can affect tattoos before starting treatment.